![Exicure Inc](/common/images/company/N_XCUR.png)
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more
Exicure, Inc. (Nasdaq: XCUR, the βCompanyβ), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1719 | 52.3925632429 | 0.3281 | 0.5806 | 0.2914 | 32677 | 0.31854786 | CS |
4 | 0.176 | 54.3209876543 | 0.324 | 0.5806 | 0.2914 | 27070 | 0.31598555 | CS |
12 | -0.018 | -3.4749034749 | 0.518 | 0.8549 | 0.2914 | 332302 | 0.4587382 | CS |
26 | -0.1043 | -17.259639252 | 0.6043 | 0.8549 | 0.2914 | 260656 | 0.53965122 | CS |
52 | -0.75 | -60 | 1.25 | 1.25 | 0.2914 | 336169 | 0.57334575 | CS |
156 | -0.9 | -64.2857142857 | 1.4 | 3.24 | 0.0846 | 2612764 | 0.35408031 | CS |
260 | -1.7 | -77.2727272727 | 2.2 | 3.84 | 0.0846 | 1719941 | 0.51651279 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.